Bo Anders Ljungqvist
Geschäftsführer bei RhoVac ApS
Ursprung des Netzwerks ersten Grades von Bo Anders Ljungqvist
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Extinct | Biotechnology | 9 | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
RhoVac ApS
 RhoVac ApS Pharmaceuticals: MajorHealth Technology Part of Chosa Oncology AB, RhoVac ApS is a Danish company that aims to prevent cancer recurrence and progression after primary tumor therapy. The company is based in Hørsholm, Denmark. The company's clinical phase II product, iCIP™ - Precision LiPlaCis® & DRP® with Breakthrough designation option, consists of LiPlaCis® and its Drug Response. Anders Månsson has been the CEO of the company since 2019.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Invest AD Asset Management PJSC
 Invest AD Asset Management PJSC Financial ConglomeratesFinance Invest AD Asset Management PJSC (Invest AD) is the sovereign wealth manager of government-owned Abu Dhabi Investment Council. The firm was founded in 1977 and is headquartered in Abu Dhabi. Invest AD provides asset management services to international high-net worth individuals and institutions.
2
| Subsidiary | Financial Conglomerates | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Bo Anders Ljungqvist
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Coegin Pharma AS
 Coegin Pharma AS Pharmaceuticals: MajorHealth Technology Coegin Pharma AS provides therapeutics that addresses inflammatory diseases. The company was founded by Berit Johansen on January 3, 2005 and is headquartered in Trondheim, Norway. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Chief Executive Officer Chairman | |
| University of Copenhagen | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
| COEGIN PHARMA AB | Pharmaceuticals: Major | Chief Executive Officer Chairman Chief Executive Officer | |
| University of Lund | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
Medicon Valley Alliance FMBA
 Medicon Valley Alliance FMBA Miscellaneous Commercial ServicesCommercial Services Medicon Valley Alliance FMBA operates a life science cluster that spans across Denmark and Sweden. The non-profit company is based in the Medicon Valley region. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| Copenhagen Business School | College/University | Undergraduate Degree Graduate Degree | |
Orbit Genomics, Inc.
 Orbit Genomics, Inc. Packaged SoftwareTechnology Services Orbit Genomics, Inc. operates as a technology platform for early disease detection, treatment, and prevention of diseases. The company is based in Boulder, CO. The company was founded by Elizabeth Willis, Harold Garner. Elizabeth Willis has been the CEO since incorporation. | Packaged Software | Director/Board Member Chairman | |
Regenesance BV
 Regenesance BV Drugstore ChainsRetail Trade Regenesance BV develops drugs for the treatment of neurodegenerative and immune mediated disorders. Its products include Regenemab, a monoclonal antibody for multiple indications like PNH, myasthenia gravis, amyotrophic lateral sclerosis, and multiples sclerosis. The company was founded by Valeria Ramaglia, Mikael Orum, Frank Baas and Kees Fluiter in 2009 is headquartered in Amsterdam, the Netherlands. | Drugstore Chains | Founder Chairman | |
| Ventac Partners LLC | Founder Founder | ||
| CASiGEN Pharma Ltd. | Chairman Chairman | ||
Edvince AB
 Edvince AB BiotechnologyHealth Technology Edvince AB engages in clinical research and development services. It operates as a biotech company that focuses on a new form of emergency treatment for stroke. The company was founded by Lars Ingvar Herbert Edvinsson in 2003 and is headquartered in Lund, Sweden. | Biotechnology | Chief Executive Officer Chairman | |
| Neuroscience Technologies Ltd. | Chairman Director/Board Member | ||
Lifandis AS
 Lifandis AS Internet Software/ServicesTechnology Services Lifandis AS provides access to a wealth of biological samples. It offers data and biological material from the HUNT studies. The company was founded in 2007 and is headquartered in Levanger, Norway. | Internet Software/Services | Chairman Chairman | |
| IDOGEN AB (PUBL) | Biotechnology | Director/Board Member Director/Board Member | |
Survac ApS
 Survac ApS Pharmaceuticals: OtherHealth Technology Survac ApS specializes in the development of peptide based therapeutic cancer vaccines. It offers the vaccine candidates for licensing and collaboration agreements. The company's vaccine is being examined in clinical phase I & II trials. Survac was founded in 2003 and is located in Hellerup, Denmark | Pharmaceuticals: Other | Chief Administrative Officer | |
Rechon Life Science AB
 Rechon Life Science AB Pharmaceuticals: MajorHealth Technology Rechon Life Science AB manufactures medicines. It specializes in aseptic injectables and sprays for nasal and oral administration. The firm's products include Iron Sucrose Injection. The firm's services include formulation and analytical development, clinical trial, stability studies, and storage and distritutions. The company is headquartered in Limhamn, Sweden. | Pharmaceuticals: Major | Sales & Marketing | |
Unimedic AB
 Unimedic AB Pharmaceuticals: MajorHealth Technology Unimedic AB manufactures and sells pharmaceuticals and chemical engineering products. It offers a wide range of licensed and unlicensed medicines and extemporaneous pharmaceuticals as well as non-prescription heath care products and pharmaceutical aids. The company was founded by Nils Ivrell, Lennart Leyoberg, and Kenth-Olov Norman in 1992 and is headquartered in Matfors, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| ICONOVO AB | Pharmaceuticals: Major | Chairman | |
| CANTARGIA AB | Pharmaceuticals: Major | Director/Board Member | |
Swedish Growth Fund Holding AB
 Swedish Growth Fund Holding AB Real Estate DevelopmentFinance Swedish Growth Fund Holding AB owns and manages movable property. The company is headquartered in Malmo, Sweden. | Real Estate Development | Chairman | |
Asgard Therapeutics AB
 Asgard Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Asgard Therapeutics AB engages in biotechnological research and development activities. It is in use of cellular reprogramming in cancer immunotherapy, which forces cancer cells to present their own antigens to the immune system, triggering expansion of cancer cell-specific killer T cells and cancer elimination. The company was founded by Filipe Pereira, Cristiana Pires and Fábio Rosa in 2018 and is headquartered in Lund, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
| CIRCIO HOLDING ASA | Biotechnology | Chief Executive Officer | |
| XSPRAY PHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
| FOLLICUM AB (PUBL) | Pharmaceuticals: Major | Corporate Officer/Principal | |
Takeda Pharmaceuticals International AG
 Takeda Pharmaceuticals International AG Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals International GmbH develops, manufactures, and distributes pharmaceutical products. It offers medicines in therapeutic areas, such as, cardiovascular and metabolic, oncology, central nervous system, respiratory and immunology, general medicine, and vaccines. The firm also provides packaging, development, contract manufacturing and quality control services. Takeda Pharmaceuticals International was founded in 1874 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Sales & Marketing | |
Nycomed AB
 Nycomed AB Pharmaceuticals: MajorHealth Technology Nycomed AB With a broad portfolio of products and a powerful pipeline, they work in a wide range of therapeutic areas, particularly cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. Nycomed engaged in all aspects of a product's life, from research and development to customer relations. They also work closely with innovative research-based companies, constantly looking for products with real promise for patients. They believe that everything do matters to someone. So they work carefully to make sure they get what they do right. They focus on results and respond quickly to the needs of patients and healthcare providers, giving them the best possible experience from working with clients. By doing this, they can achieve vision of being the preferred pharmaceutical company. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| COLABITOIL SWEDEN AB (PUBL) | Miscellaneous Commercial Services | Director/Board Member | |
Copenhagen Institute for Futures Studies
 Copenhagen Institute for Futures Studies Miscellaneous Commercial ServicesCommercial Services Copenhagen Institute for Futures Studies is an institution that specializes in providing futures studies. The non-profit company is based in Copenhagen, Denmark. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Louis Pasteur University | College/University | Doctorate Degree | |
Swedish Growth Fund AB
 Swedish Growth Fund AB Investment ManagersFinance Swedish Growth Fund is focusing on biotech, life science and IT companies located in the south of Sweden and in Denmark. The fund makes investments ranging between SEK 5-10 million in companies estimated to be 6-18 months away from an IPO. | Investment Managers | Founder | |
Respiratorius AB
 Respiratorius AB Pharmaceuticals: MajorHealth Technology Respiratorius AB engages in the development of drug candidates for Chronic Obstructive Pulmonary Disease, asthma, and cancer. The company was founded by Lars Christer Fedrik Fåhraeus and Staffan Skogwall in 1999 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| AB Glumslövs Tegelbruk | Director/Board Member | ||
| LIDDS AB | Pharmaceuticals: Major | Chief Executive Officer | |
| Cenexum Technologies ApS | Chairman | ||
APIM Therapeutics AS
 APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | Pharmaceuticals: Major | Director/Board Member | |
| Technical University of Denmark | College/University | Director/Board Member | |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Biotechnology | Chairman | |
IXALTIS SAS
 IXALTIS SAS Pharmaceuticals: MajorHealth Technology IXALTIS SAS develops therapeutics to treat genitourinary tract disorders with unsatisfied medical need. The company was founded by Christian Chavy, Philippe Lluel, Roberto Gradnik, Stefano Palea, Pascal Rischmann, and Xavier Gamé in 2012 and is headquartered in Archamps, France. | Pharmaceuticals: Major | Director/Board Member | |
CUBE Labs Srl
 CUBE Labs Srl Investment ManagersFinance Cube Labs Srl (Cube Labs) is a venture capital subsidiary of Cube Labs SpA founded in 2013 by Filippo Surace and Renato del Grosso. The firm is headquartered in Rome, Italy. | Investment Managers | Consultant / Advisor | |
Oncoinvent AS
 Oncoinvent AS Pharmaceuticals: MajorHealth Technology Oncoinvent AS develops antibody based therapeutic molecules for cancer treatment. It offers antigen-binding domains that develops coupling to nanoparticles and drug candidates. The firm provides antibodies (the OI-antibodies) with clinical relevant binding-specificity and also designs molecules and drug conjugates for treatment of specific cancer diseases. The company was founded by Tina Bjornlund Bonsdorff, ?yvind Sverre Bruland, Roy Hartvig Larsen, and Thora Johanna Jonasdottir in 2010 and is headquartered in Oslo, Norway. | Pharmaceuticals: Major | Chief Executive Officer | |
| Anders Månsson Business Development AB | Chief Executive Officer | ||
Bonsig AB
 Bonsig AB Real Estate DevelopmentFinance Bonsig AB provides property rental and management services. | Real Estate Development | Director/Board Member | |
| AMNIOTICS AB | Biotechnology | Chief Executive Officer | |
| EQL PHARMA AB | Pharmaceuticals: Generic | Chairman | |
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Pharmaceuticals: Major | Chairman | |
| Business School Lausanne | College/University | Masters Business Admin | |
Baltic Gaming AB
 Baltic Gaming AB Media ConglomeratesConsumer Services Baltic Gaming AB is a private company that engages in gaming and betting activities. The company is based in Sigtuna, Sweden. The CEO of the Swedish company is Peter Åström. | Media Conglomerates | Director/Board Member |
Statistik
International
| Schweden | 26 |
| Dänemark | 8 |
| Norwegen | 6 |
| Vereinigte Staaten | 4 |
| Schweiz | 3 |
Sektoral
| Health Technology | 24 |
| Consumer Services | 8 |
| Finance | 6 |
| Commercial Services | 5 |
| Technology Services | 3 |
Operativ
| Director/Board Member | 45 |
| Chairman | 29 |
| Chief Executive Officer | 18 |
| Founder | 18 |
| Corporate Officer/Principal | 16 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Mikael Ørum | 25 |
| Lars Höckenström | 17 |
| Mikael Oerum | 17 |
| Hans Niclas Göran Lundqvist | 15 |
| Anders Månsson | 12 |
| Tore Duvold | 11 |
| Gunnar Gårdemyr | 11 |
| Bo Tandrup | 6 |
| Mads Hald Andersen | 5 |
| Jette Traulsen | 4 |
| Jannie Kogsbøll | 4 |
| Per Thor Straten | 2 |
| Sachin Mohindra | 1 |
| Pierre Rezko | 1 |
| Steffen Wad Jørgensen | 1 |
- Börse
- Insiders
- Bo Anders Ljungqvist
- Unternehmensverbindungen
